Defining Incidence and Risk Factors of Venous Thromboemolism after Hepatectomy
- 476 Downloads
The incidence of venous thromboembolism (VTE) among patients undergoing hepatic surgery is poorly defined, leading to varied use of VTE prophylaxis among surgeons. We sought to define the incidence of VTE after liver surgery and identify risk factors associated with VTE.
Incidence of VTE and associated risk factors within 90 days of hepatic resection between 2006 and 2012 at a major academic center was analyzed. Risk factors for VTE were identified using univariate and multivariate analyses.
A total of 599 patients were included in the study cohort; 30 (5.0 %) had a prior history of VTE. The indications for surgery were malignant (90.8 %) and benign lesions (9.2 %). The majority of patients underwent a minor hepatectomy (<3 Couinaud segments; n = 402, 67.1 %) while 195 (32.6 %) patients underwent a major hepatectomy (≥3 Couinaud segments). Three hundred seven (51.3 %) patients were started on VTE chemoprophylaxis preoperatively with 407 (67.8 %) patients receiving VTE chemoprophylaxis within 24 h of surgery. Twenty-eight (4.7 %) patients developed VTE; 20 (3.3 %) had deep venous thrombosis (DVT), 11 (1.8 %) had pulmonary embolism (PE), and three (0.5 %) developed both DVT and PE. Among the VTE patients, 23 (82.1 %) had received VTE chemoprophylaxis. On multivariate analyses, history of VTE (odds ratio [OR] 4.51, 95 % confidence interval [CI] 1.81–17.22, P = 0.03), prolonged operative time (OR 1.17 per additional hour, 95 % CI 1.04–1.32, P = 0.009), and increased length of stay (LOS) (OR 1.07, 95 % CI 1.02–1.12, P = 0.01) were independent risk factors for VTE.
VTE within 90 days of hepatic resection is common, occurring in nearly one in 20 patients. Most VTE events occurred among patients who received current best practice prophylaxis for VTE. More aggressive strategies to identify and reduce the risk of VTE in patients at highest risk of VTE, including those with a history of VTE, extended operative time, and prolonged LOS, are warranted.
KeywordsVenous thromboembolism Hepatectomy Prophylaxis Bleeding DVT
- 1.Collins, R., A. Scrimgeour, S. Yusuf and R. Peto, Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med, 1988. 318(18): p. 1162–73.PubMedCrossRefGoogle Scholar
- 4.Gould, M.K., D.A. Garcia, S.M. Wren, et al., Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012. 141(2 Suppl): p. e227S–77S.PubMedCentralPubMedGoogle Scholar
- 15.Barton, J.S., G.M. Riha, J.A. Differding, et al., Coagulopathy after a liver resection: is it over diagnosed and over treated? HPB (Oxford), 2013.Google Scholar
- 28.McLeod, R.S., W.H. Geerts, K.W. Sniderman, et al., Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial. Ann Surg, 2001. 233(3): p. 438–44.PubMedCentralPubMedCrossRefGoogle Scholar